Sunday, September 17, 2006

Uroplasty Receives Approvable Letter From FDA For Macroplastique


Uroplasty Receives Approvable Letter From FDA For Macroplastique
Trading Markets, CA - Sep 13, 2006 approvable letter from FDA relating to its pre-market approval application for Macroplastique Implants for the treatment of female stress urinary incontinence.

EastMed Announces $1.5 Million Financing from InNOVAcorp and BDC
TechFinance, Canada - Sep 14, 2006 to support the launch of its new product that will be marketed under the brand name Uresta(TM), designed to help women control stress urinary incontinence (SUI

Bankruptcy judge OKs Mesaba financing plan
Pioneer Press, MN - Sep 14, 2006 Minneapolis-based medical-device maker Uroplasty said that US regulators will approve its product to treat female stress urinary incontinence if the company

Q-Med: Q-Med's First Product in the Field of Body Augmentations
Business Wire (press release), CA - Sep 12, 2006 the treatment of vesicoureteral reflux (a malformation of the urinary bladder) in children and ZUIDEX, for the treatment of stress urinary incontinence in women

Complete Health Calendar
Quad City Times, IA - Sep 14, 2006 3. Dr. Ruger Lubbers will discuss new and minimally invasive solutions to treat female stress urinary incontinence, sponsored by Mentor Corp., free.

Incontinence